Fri, Sep 19, 2014, 8:13 AM EDT - U.S. Markets open in 1 hr 17 mins

Recent

% | $
Quotes you view appear here for quick access.

Threshold Pharmaceuticals Inc. Message Board

  • dawginlife dawginlife Apr 17, 2014 3:21 PM Flag

    some fool is probably doing a pairs trade with thld and cytr.

    idiot can't see the forest for the trees. however, that's not as big as mistake when you consider that this idiot is long cytr and short thld. i would love to see him roast in a few months when the interim STS results are released.

    cheers

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • btw, what idiot are you talking about?

    • interim.. we can only hope.

      as for cytr.. at least they had the "dream team" lol. we have...ummm.. beachbum lmao.

      we will bottom out around June around low 3s then probably run back to 5s by July. Then hopefully we can see the data. im still not sure if we will have some kind of data if we have to continue to completion of the trial.

      • 1 Reply to mclim73
      • mclim, i doubt the price action will work out the way you think. first, if you look at the milestone chart provided by the company, interim sts is projected to come out btw jun and jul. second, thld shorts may be idiots, but they are traders b/f they are speculators so, i doubt any short traders will want to hold their position going into july. my bet is shorts will look to cover their position around the end of may.

        as for the price going into the low 3s, that all depends on the biotech bear market. this down turn was not due to any fundamental change to the sector but more on valuation. looking around the sector now, i sure see a lot of cheap companies so this sector sell off has probably leveled off and we may even see some price recovery soon.

 
THLD
4.69+0.01(+0.21%)Sep 18 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.